Evaluating the Impact of Non-pharmaceutical Measures on the Incidence of Influenza-like Illness (ILI) among K-12 Students in the United States

Post Date

November 13th 2015

Application Due Date

January 15th 2016

Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.

Funding Opportunity Number

RFA-CK-16-005

CFDA Number(s)

93.084

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

2

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Additional Information on Eligibility Applications submitted under this funding opportunity announcement must not include activities that overlap with simultaneously-funded research already awarded to applicants under other awards.

Funding

• Estimated Total Funding:

  $4000000

• Award Range:

  $400000 - $500000

Grant Description

The project aims to evaluate the impact of non-pharmaceutical measures (NPIs) on incidence of influenza-like infections (ILI) among K-12 students in the United States via multi-year community randomized trials. The NPIs of interest will include at least one social distancing measure of interest, and an improved personal hygiene (hand washing and/or alcohol-based hand sanitizer use) and environmental hygiene practice (cleaning of frequently touched surfaces) within schools. The social distancing measures of interest include, but are not limited to, (1) reducing class size to allow for increases in space between students to at least 3 ft, and (2) reducing duration of the school day (e.g. by offering a certain proportion of daily school instruction via remote learning systems). Additionally, use of disposable medical face masks can be included as a source control measure for students exhibiting respiratory symptoms with or without fever while at school. The outcomes of interest include (1) incidence of ILI-associated student absenteeism and (2) incidence of laboratory-confirmed respiratory infections as detected by multiplex PCR assay.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  Deborah Loveys
  hft6@cdc.gov
  

• Agency Mailing Address:

  Grants Policy

• Agency Email Address:

  hft6@cdc.gov

• Location:

  Centers for Disease Control and Prevention

• More Information: